Assessing the Predictive Value of Kolmogorov-Arnold Networks for the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: A Comparative Machine Learning Study.
Source check: Source checked. Not independent scientific confirmation.
Finding: In a prospective single-center cohort of 890 patients undergoing primary PCI for STEMI, the study compared supervised models for predicting no-reflow. Kolmogorov-Arnold Network and XGBoost models reported AUC above 0.98 and F1 above 0.95, exceeding logistic-regression and decision-tree comparators in the study. External validation is still needed.
Technology: Kolmogorov-Arnold Network and XGBoost classifiers predicted no-reflow after primary PCI; ANOVA F-statistics selected features, and SHAP described model associations.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Kolmogorov-Arnold Network and XGBoost classifiers predicted no-reflow after primary PCI; ANOVA F-statistics selected features, and SHAP described model associations.
- Test and result
- The primary publisher abstract reports 890 consecutive STEMI patients in a prospective single-center study; KAN and XGBoost had AUC above 0.98 and F1 above 0.95, outperforming logistic regression and decision trees. The input full-text review confirms the cohort, reference and validation details; further multicenter external validation is required.
- Limitation / still unknown
- The evaluation is from one center; the source calls for multicenter external validation before generalizing performance or clinical risk-assessment use.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://archivestsc.com/jvi.aspx?un=TKDA-02730&volume=54&issue=3
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.